Current problems in cardiology · 2023
Characterization of Patients With Heart Failure of Chagas Etiology in Colombia: An Analysis Based on the Colombian Registry of Heart Failure (RECOLFACA).
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Echeverría Luis Eduardo, Saldarriaga Clara, Rivera-Toquica Alex Arnulfo, Gómez-Ochoa Sergio Alejandro, Cadena-Bonfanti Alberto José, Zarama-Márquez Mario Hernán, Ramírez-Puentes Elkin Giovanni, Bustamante Rafael Ignacio, Palacio Rolando, Ávila-Barros Luis Manuel, Campbell-Quintero Sebastián, Morales-Rodríguez Lisbeth Natalia, López-Ponce de León Juan David, Buitrago Andrés Felipe, Martínez-Carreño Erika, Gómez-Mesa Juan Esteban, RECOLFACA Investigators
Аннотация
Chronic Chagas cardiomyopathy (CCM) represents a relevant origin of Heart Failure (HF) in countries where the disease is endemic. CCM exhibits distinct myocardial involvement and is associated with a poorer prognosis compared to different HF etiologies. The aim is to explain the features and prognosis of individuals with HF resultant to CCM registered in the Colombian Registry of Heart Failure (RECOLFACA). RECOLFACA registry enrolled 2528 adult patients with HF. A comparison was made between patients diagnosed with CCM and those diagnosed with other etiologies of HF. Eighty-eight patients (3.5%) present CCM diagnosis. The individuals diagnosed with both HF and CCM were notably younger in age, had less comorbidities, poorer functional class, and significantly inferior ejection fraction. Finally, the presence of CCM diagnosis was linked to a substantially elevated mortality risk throughout the follow-up period (HR 2.01; 95% CI, 1.01-4.00) according to a multivariate model adjusted. CCM represents an important etiology of HF in Colombia, drawing attention to a distinct clinical profile and a higher risk of mortality compared to other HF etiologies.